AstraZeneca Expands China Biotech Strategy With New Cell Therapy Investment in Shanghai

AstraZeneca Expands China Biotech Strategy With New Cell Therapy Investment in Shanghai

  • March 19, 2026

AstraZeneca is deepening its presence in China’s fast growing biotech sector with plans to build a new cell therapy facility in Shanghai, reinforcing its long term commitment to advanced medical innovation in the region. The investment forms part of a broader expansion strategy

Innovent Becomes First Chinese Biotech Firm to Market a Weight Loss Drug and Joins the Hang Seng Index

Innovent Becomes First Chinese Biotech Firm to Market a Weight Loss Drug and Joins the Hang Seng Index

  • November 25, 2025

Innovent Biologics, a leading biotech company headquartered in Jiangsu province, is set to join the Hang Seng Index next month, marking a major milestone for both the firm and the broader Chinese pharmaceutical industry. The announcement was made as part of the benchmark’s